Key facts
- This page summarizes Gabriele M. Cerrone's Form 3 filing for OKYO Pharma Ltd (OKYO).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 18 Mar 2026, 20:35.
Gabriele M. Cerrone - 18 Mar 2026 Form 3 Insider Report for OKYO Pharma Ltd (OKYO)
- Reporting relationship
- Director, 10%+ Owner
- Issuer ticker
- OKYO
- Reported as of
- 18 Mar 2026
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 18 Mar 2026, 20:35:59 UTC
- Prior SEC filing
- 16 Jun 2025
- Next SEC filing
- 10 Jun 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Gabriele Cerrone
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Gabriele M. Cerrone filed Form 3 for OKYO Pharma Ltd (OKYO) on 18 Mar 2026.
Change
- Previous filing in this sequence was filed on 16 Jun 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reporting Owners (1)
CIK 0001139306
Primary reporting owner
CERRONE GABRIELE M
- Relationship
- Director, 10%+ Owner
- Address
- C/O OKYO PHARMA LTD,, 14-15 CONDUIT STREET, LONDON, UNITED KINGDOM
- Signature
- /s/ Gabriele Cerrone
- Signature date
- 18 Mar 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
OKYO
holding
COMMON STOCK
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 10,526,416
- Date
- 18 Mar 2026
- Ownership
- Direct
* marks a reported price that did not pass the local price check.